Featured
Multiple Myeloma Treatment: A Long-Term, Stage-Based Journey
Outbreak Watch Oct 17, 2026
Trial Briefs Oct 16, 2026
Drug Approvals Oct 15, 2026
The FDA approves ropeginterferon alfa-2b-njft for essential thrombocythemia, the first new treatment for the rare...
Breast cancer diagnosis taught Dr. Molly Greenwade, an oncologist, lessons on early detection while juggling...
A study in Nature overturns the assumption that longer sleep is universally better for aging....
Read our latest Drug Approvals articles.
Therapeutic phlebotomy is one of the key treatments for managing polycythemia vera risks, helping lower...
Most breast bruises are not linked to breast cancer unless they persist beyond two weeks,...
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial period.
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial period.
Discover the latest stroke rehabilitation guidelines from American Heart Association for improved recovery outcomes with updated recommendations.
FDA approves Oveporexton (Orzeyful) for Type 1 Narcolepsy, first therapy to restore orexin signaling. Learn how it tackles the root...
FDA Week: New blood test for Alzheimer's disease approved. See how Elecsys pTau217 helps identify amyloid pathology in adults 55...
Botox migraine therapy is gaining attention as it shows relief for migraine and spasticity, providing a targeted alternative to systemic...
FDA approval of Avulux migraine lenses offers an over‑the‑counter solution to reduce photophobia for migraine sufferers aged 12+, complementing existing...
Gene therapy MPS II stalls as the FDA places a clinical hold on RGX-121 after MRI scans revealed spinal abnormalities,...
Factor XIa inhibitors are emerging as a promising antithrombotic option to reduce recurrent strokes, offering better protection than aspirin or...
FDA approves new treatments for brain disorders, including Tourette syndrome, with priority review for ecopipam drug application.
New phase 2 trial finds oral cannabis oil failed to reduce chronic pain in Parkinson patients. Read the latest analysis...